In the TCGA cohort, higher expression of RNF44 might predict earlier hepatocellular carcinoma, increased probability of tumor cachexia, poorer histologic grade, larger tumor size, higher pathologic stage, and higher blood AFP values. This evidence concerns the gene RNF44 and hepatocellular carcinoma.